Cardiac Autonomic Receptors
The heart contains β1-adrenergic receptors (primarily in myocardium), β2-adrenergic receptors (in myocardium and coronary vessels), α1-adrenergic receptors, and M2-muscarinic receptors (predominantly in atria) that mediate autonomic nervous system regulation of cardiac function. 1
Sympathetic (Adrenergic) Receptors
Beta-Adrenergic Receptors
β1-adrenergic receptors are located primarily in the myocardium and represent the dominant cardiac adrenergic receptor subtype. When stimulated by norepinephrine or epinephrine, they produce:
- Increased myocardial contractility (positive inotropy)
- Increased sinus node rate (positive chronotropy)
- Increased AV node conduction velocity (positive dromotropy)
- Decreased systolic blood pressure through these combined effects 1
β2-adrenergic receptors are present in both myocardium and coronary vessels. Norepinephrine stimulates coronary vessel β2-receptors to increase stroke volume and coronary blood flow 2. These receptors are distributed relatively evenly throughout the human heart 3.
The β1 and β2 subtypes work synergistically—dopamine at infusion rates of 2-15 μg/kg/min stimulates β1-receptors with increased myocardial contractility, though at the cost of tachycardia and arrhythmia risk 2.
Alpha-Adrenergic Receptors
α1-adrenergic receptors exist in the human heart, though their distribution and functional role remain less well-characterized compared to beta receptors 3. During atrial fibrillation, sympathetic activation increases coronary vascular resistance through alpha-adrenergic receptor stimulation 4.
α2-adrenergic receptors may exist as prejunctional receptors, though evidence remains limited 3.
Parasympathetic (Cholinergic) Receptors
M2-muscarinic receptors are the primary parasympathetic receptors in the heart, distributed heterogeneously with higher concentrations in atria than ventricles 3. Acetylcholine released from vagal nerve terminals activates these receptors to produce:
- Decreased heart rate directly in atria
- Decreased force of contraction indirectly in ventricles
- Impeded AV nodal conduction through muscarinic receptor activation 5
The vagal pathway terminates at the sinoatrial node, where M2-receptor stimulation produces bradycardia 6. Parasympathetic neurons originate from the nucleus ambiguus and dorsal motor nucleus, working with postganglionic neurons in ganglionated plexi to provide diffuse control over cardiac regions 6.
Functional Integration
The autonomic receptors operate through complex, synergistic interactions rather than simple antagonism. Beta-adrenergic stimulation increases AC-cAMP/PKA signaling, while cholinergic stimulation inactivates adenylyl cyclase 7. These opposing signals are not merely additive—the phenomenon of "accentuated antagonism" occurs when both systems are simultaneously activated 7.
Critical clinical point: In pathological states like heart failure, the distribution of β1- and β2-adrenoceptors can be altered by disease or pharmacological interventions (such as beta-blocker treatment), while M2-receptors remain only marginally affected 3. This differential remodeling has important therapeutic implications for autonomic modulation strategies.
The cardiac intrinsic nervous system contains local circuit neurons that integrate afferent and efferent signals, allowing precise monitoring and regulation even when disconnected from higher-order structures 6. This redundancy ensures appropriate modulation can occur despite focal lesions 6.